BIOMARKERS

Molecular Biopsy of Human Tumors

Biomarkers for Lung cancer

1. EGFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
2. TP53
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
3. AKT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
4. ERBB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
5. BCL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
6. PR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
7. CEACAM5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
8. MAPK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
9. KRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
10. MYC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
11. CDKN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
12. ESR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
13. ALK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
14. PIK3CA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
15. ER
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
16. ROS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
17. HRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
18. ITK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
19. JUN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
20. Ki-67
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
21. MTOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
22. FBXW7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
23. MS4A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
24. IL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
25. NKX2-1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
26. AR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
27. SRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
28. ENO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
29. CTLA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
30. RB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
31. RHOH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
32. KDR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
33. TG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
34. TIMP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
35. MUC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
36. FGFR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
37. MAX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
38. FAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
39. TSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
40. BRAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
41. LDH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
42. STAT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
43. PTEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
44. TSC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
45. KIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
46. APC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
47. hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
48. EML4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
49. HIF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
50. GNAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
51. TP63
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
52. PDCD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
53. AFP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
54. BRCA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
55. ABL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
56. PSA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
57. MUC16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
58. CALCB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
59. MET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
60. TERT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
61. SDHB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
62. MDM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
63. ATM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
64. RHOA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
65. FEV
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
66. ABCG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
67. CD274
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
68. CXCR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
69. RET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
70. CCDC6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
71. FH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
72. STK11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
73. ABL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
74. SERPINE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
75. PRF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
76. SPEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
77. CD79A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
78. FUS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
79. ERBB3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
80. FHIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
81. NFE2L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
82. HSP90AA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
83. CDK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
84. MDM4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
85. BRD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
86. CDKN1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
87. DDIT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
88. NRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
89. POU5F1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
90. BCR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
91. SMAD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
92. ERCC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
93. RAF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
94. uPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
95. PRKAR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
96. MYCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
97. NTRK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
98. MAP2K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
99. PTPRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
100. PTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
101. SOX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
102. GATA3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
103. BLM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
104. FANCA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
105. Beta-hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
106. SDHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
107. FOXP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
108. PDGFRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
109. RAC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
110. SMAD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
111. MLH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
112. CgA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
113. HLA-A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
114. NCKIPSD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
115. CALR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
116. WT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
117. CYP2D6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
118. RARA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
119. CREBBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
120. NOTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
121. SMAD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
122. FLCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
123. KEAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
124. EZH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
125. STIL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
126. ARID1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
127. CHEK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
128. EP300
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
129. NF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
130. FGFR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
131. GOPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
132. BRCA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
133. CUX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
134. ERBB4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
135. PPFIBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
136. EWSR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
137. ATR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
138. CCND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
139. JAK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
140. HER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
141. ATRX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
142. CDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
143. YWHAE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
144. FLT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
145. CBL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
146. KMT2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
147. ELN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
148. MALAT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
149. CDX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
150. FGFR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
151. POLE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
152. CDK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
153. DICER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
154. VHL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
155. MSH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
156. PTPN11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
157. U2AF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
158. MEN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
159. BIRC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
160. HMGA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
161. SSX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
162. TRIM27
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
163. MYB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
164. XPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
165. BAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
166. SMARCA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
167. KIF5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
168. FOXO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
169. PDGFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
170. CASP8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
171. NPM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
172. XPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
173. DDR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
174. ERCC5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
175. FUBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
176. NDRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
177. SS18
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
178. AKT2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
179. FOXO3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
180. NT5C2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
181. ERG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
182. PDGFRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
183. NBN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
184. REL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
185. FES
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
186. NF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
187. CYLD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
188. FLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
189. CIC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
190. PML
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
191. ERCC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
192. SMARCB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
193. SMO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
194. STAT5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
195. CD74
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
196. NUTM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
197. TAL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
198. KLF6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
199. LMNA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
200. CTNNB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
201. PAX8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
202. WIF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
203. CLIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
204. EBF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
205. SALL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
206. TOP2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
207. MALT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
208. TFE3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
209. ARNT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
210. JAK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
211. MAP2K4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
212. RPL22
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
213. SDHC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
214. ELF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
215. CDH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
216. WFDC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
217. LCK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
218. DNMT3A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
219. IGH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
220. KLF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
221. WAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
222. AXIN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
223. ETV4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
224. IL6ST
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
225. MYD88
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
226. MYOD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
227. NRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
228. SFPQ
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
229. SSX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
230. CDKN2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
231. ETV5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
232. FGFR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
233. FANCD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
234. NOTCH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
235. PAX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
236. PDCD1LG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
237. Neurokinin
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
238. CARS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
239. FOXA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
240. IDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
241. MAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
242. MUTYH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
243. PAX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
244. PCSK7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
245. TOP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
246. MYCL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
247. SDHD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
248. STAT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
249. TFRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
250. TNFAIP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
251. ETV6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
252. MITF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
253. SYK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
254. HLF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
255. PIM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
256. PPM1D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
257. CANT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
258. CRTC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
259. DROSHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
260. FANCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
261. HOXA9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
262. IL7R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
263. SLC34A2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
264. ALDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
265. CCND2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
266. HERPUD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
267. KLK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
268. NTRK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
269. RUNX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
270. TGFBR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
271. AXIN2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
272. GPC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
273. HMGA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
274. SOCS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
275. SPECC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
276. TCF7L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
277. TPR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
278. ATF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
279. COL1A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
280. MAP2K2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
281. SUZ12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
282. TFG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
283. ARID1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
284. ERCC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
285. FLI1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
286. HEY1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
287. JAK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
288. PTPN13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
289. TNFRSF17
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
290. CCNE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
291. EIF4A2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
292. HOXD13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
293. MSH6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
294. NR4A3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
295. TRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
296. XPO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
297. DDX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
298. SND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
299. TPM3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
300. FANCF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
301. HNRNPA2B1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
302. IDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
303. MAP3K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
304. MPL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
305. ZNF331
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
306. BCL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
307. BTK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
308. CREB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
309. CTCF
    [Clinical Outcome] [Diagnosis] [